Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Two doctors fell in love while researching different types of rare cancers at MD Anderson Cancer Center. They were coworkers ...

Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...

During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...

In this Healio Video Perspective from Telling It Like It Is, Cynthia Matossian, MD, FACS, shared pearls for ophthalmologists ...

The process of separating useful molecules from mixtures of other substances accounts for 15% of the nation's energy, emits ...